Axsome Therapeutics, Inc.AXSMNASDAQ
Loading
Debt to Assets Over TimeFair Value
Percentile Rank67
3Y CAGR+7.0%
5Y CAGR+5.4%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
+7.0%/yr
vs -10.7%/yr prior
5Y CAGR
+5.4%/yr
Consistent
Acceleration
+17.7pp
Accelerating
Percentile
P67
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
3 yr
Consecutive growthFair Value
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.35 | +3.1% |
| 2024 | 0.34 | +7.1% |
| 2023 | 0.32 | +10.9% |
| 2022 | 0.29 | -49.6% |
| 2021 | 0.57 | +110.3% |
| 2020 | 0.27 | +197.9% |
| 2019 | 0.09 | -79.9% |
| 2018 | 0.45 | +60.9% |
| 2017 | 0.28 | +9.6% |
| 2016 | 0.25 | - |